Klausner Urges Emphasis On Research, Warns Against Shift To Health Programs.
Gregory Reaman Elected Chairman, C.O.G.; NCI Seeks Nominations For Consumer Group. “We Need A Long-Term Commitment” To Discovery.
First NCI Director To Resign Due To Presidential Election?
EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor.
Perot Systems To Provide IT Support For US Oncology Enterprise Applications.
Bayer’s HER-2/neu Blood Test Cleared By FDA For Marketing.
Firm Wins Patent For Method, Apparatus For Cryoablation.
Trending Stories
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.” - At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
